Citadel Advisors’s Medigus Series C Warrant MDGSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-11,946
Closed -$505 – 15609
2023
Q2
$505 Buy
+11,946
New +$742 ﹤0.01% 14098

Citadel Advisors's MDGSW Position: Q3 2023 in Review

Citadel Advisors sold out of Medigus Series C Warrant (MDGSW) in Q3 2023, closing a stake of 11,946 shares — an estimated $505 sold.

Citadel Advisors first reported a position in MDGSW in Q2 2023 and held it in 1 quarter. The position peaked at $505 in Q2 2023. 0 funds tracked by Wall St. Rank hold MDGSW as of Q3 2023.

  • Citadel Advisors reported no remaining Medigus Series C Warrant position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 11,946 Medigus Series C Warrant shares in Q3 2023, an estimated $505.
  • Citadel Advisors first reported a position in Medigus Series C Warrant in Q2 2023 and held it in 1 quarter.
  • Citadel Advisors's Medigus Series C Warrant position peaked at $505 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Medigus Series C Warrant as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.